Medical devices, healthcare technology and the business of care
PMA approval · P140018

VENASEAL CLOSURE SYSTEM

Medtronic Vascular, Inc. · Decision date Feb 20, 2015

MEDTECHLEDGER EXPLANATIONP140018

What did the FDA approve?

The FDA record P140018 lists an approval dated 2015-02-20 for the VenaSeal Closure System, submitted by Medtronic Vascular, Inc. under product code PJQ (agent, occluding, vascular, permanent) in the Cardiovascular specialty. The supplied fields show no supplement type or supplement reason, so the entry is described as an approval of the system itself rather than a later change to an existing approval.

The stated indication covers permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein, through endovascular embolization with coaptation, for adults with clinically symptomatic venous reflux diagnosed by duplex ultrasound. That wording is the sponsor's reported intended use; it is not independent proof of safety or clinical effectiveness, and the record gives no trial data or performance results.

FDA approval order statement

APPROVAL FOR THE VENASEAL CLOSURE SYSTEM. THIS DEVICE IS INDICATED FOR THE PERMANENT CLOSURE OF LOWER EXTREMITY SUPERFICIAL TRUNCAL VEINS, SUCH AS THE GREAT SAPHENOUS VEIN (GSV), THROUGH ENDOVASCULAR EMBOLIZATION WITH COAPTATION. VENASEAL IS INTENDED FOR USE IN ADULTS WITH CLINICALLY SYMPTOMATIC VENOUS REFLUX AS DIAGNOSED BY DUPLEX ULTRASOUND (DUS).
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Feb 20, 2015

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140018
Regulatory pathway
Premarket approval application
Product code
PJQ
Decision code
APPR
Decision date
Feb 20, 2015
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Agent, occluding, vascular, permanent.

Product code
PJQ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P140018 received

    Application receipt date recorded by FDA.

  2. P140018 · FDA decision

    APPR

  3. P140018/S050 · Related supplement

    VenaSeal Closure System

Timeline entries are records held by MedtechLedger for P140018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140018

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA supplementOct 15, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records